PCSK9 Inhibitor
6 drugs across 2 manufacturers|0 Generic,6 Brand
Total Drugs
6
0G / 6B
Manufacturers
2
Avg $273.7695/unit
Avg 7d Change
0.00%
Across 0 drugs with changes
7d Activity
6 flat
of 6 total drugs
Class Price Trend
Monthly average NADAC price per unit, split by generic and brand
Manufacturer Breakdown
2 manufacturers producing drugs in this therapeutic class
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
REPATHA 140 MG/ML SURECLICK Evolocumab | $281.9492 per ML | — |
REPATHA 140 MG/ML SURECLICK Evolocumab | $281.9492 per ML | — |
REPATHA 140 MG/ML SYRINGE Evolocumab | $281.2448 per ML | — |
REPATHA 140 MG/ML SYRINGE Evolocumab | $281.2448 per ML | — |
PRALUENT 150 MG/ML PEN alirocumab | $258.1639 per ML | — |
PRALUENT 75 MG/ML PEN alirocumab | $258.0650 per ML | — |